Garcinia Cambogia
A tropical fruit extract containing hydroxycitric acid (HCA), promoted heavily as a fat burner. One of the most widely sold and marketed weight loss supplements. The evidence tells a different story: when only the well-conducted trials are analysed, the weight loss effect essentially disappears. A 2025 review of 14 studies found none of them demonstrated clinically significant weight loss.
Quick read · 3 min
A 2020 meta-analysis of 8 randomised controlled trials found borderline statistically significant weight loss of 1.34 kg vs.
For context — weight loss from prescription medications:
How it works
HCA (hydroxycitric acid) is proposed to inhibit an enzyme called ATP-citrate lyase, which is involved in converting excess carbohydrates into fat for storage. It may also increase serotonin levels, which could modestly reduce appetite. These mechanisms are plausible in theory — the problem is they haven't translated into meaningful effects in rigorous human trials.
What the evidence shows
A 2020 meta-analysis of 8 randomised controlled trials found borderline statistically significant weight loss of 1.34 kg vs. placebo (p=0.03). However, when only the most rigorous trials are analysed, the effect is no longer statistically significant. A 2025 scoping review of 14 studies concluded that all 14 failed to demonstrate clinically significant weight or BMI reduction. The marketing claims for garcinia cambogia are substantially stronger than the evidence supports.
The trade-off
What this tends to offer:
- ✓Affordable and widely available
What this involves:
- •No significant weight loss in well-conducted trials
- •Reports of liver damage in some products
- •Heavily marketed based on low-quality early evidence
- •Mechanism not demonstrated in human studies
Safety
Headache and GI symptoms (nausea, diarrhoea, stomach discomfort) are the most common side effects. There have been reports of liver toxicity at high doses — while rare, the FDA and NIH have noted these cases. Given the very weak evidence for benefit, the risk-benefit ratio is unfavourable. Not recommended as a weight loss treatment.
Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice
How this site is built →Last reviewed
In the Meta-analysis of 8 RCTs (Golzarand 2020), Borderline significant weight loss of 1.34 kg vs. placebo (95% CI: -2.62 to -0.07, p=0.03). Effect disappears in higher-quality trials only.
In the Systematic review of rigorous RCTs only (Onakpoya 2011), When only well-conducted trials are included, the effect of garcinia cambogia is no longer statistically significant.
Community insights
These are personal experiences shared in public online communities — not medical advice.
“This supplement was made famous by TV promotion, not by clinical evidence. The science has consistently not backed up the marketing claims.”
“If you want to try something in this price range, berberine or chitosan have much stronger evidence. Garcinia cambogia is not worth the money.”
Common questions
After reading this page, most people compare this with other supplements, look at prescription options, or check what they can do today without a prescription.
Next step most people take
Built with agentic AI tools and not a substitute for medical advice
Last reviewed: